These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients. Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845 [TBL] [Abstract][Full Text] [Related]
30. Effect of coasting on IVF cycle characteristics and outcome in short vs. long GnRH agonist protocols. Farhi J; Fisch B; Sapir O; Pinkas H; Ben-Haroush A Gynecol Endocrinol; 2010 Mar; 26(3):187-92. PubMed ID: 20148740 [TBL] [Abstract][Full Text] [Related]
31. Are gonadotropin-releasing hormone agonists losing popularity? Current trends at a large fertility center. Reh A; Krey L; Noyes N Fertil Steril; 2010 Jan; 93(1):101-8. PubMed ID: 18973891 [TBL] [Abstract][Full Text] [Related]
32. Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response. De Placido G; Mollo A; Clarizia R; Strina I; Conforti S; Alviggi C Fertil Steril; 2006 Jan; 85(1):247-50. PubMed ID: 16412769 [TBL] [Abstract][Full Text] [Related]
33. A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization. Berin I; Stein DE; Keltz MD Fertil Steril; 2010 Feb; 93(2):360-3. PubMed ID: 19131055 [TBL] [Abstract][Full Text] [Related]
34. Changes in long luteal protocol affects the number of days of stimulation: evolution of an assisted reproductive technology practice. Palmer CB; Forstein DA; Higdon HL; Boone WR J Reprod Med; 2011; 56(7-8):308-12. PubMed ID: 21838160 [TBL] [Abstract][Full Text] [Related]
35. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial. Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040 [TBL] [Abstract][Full Text] [Related]
36. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966 [TBL] [Abstract][Full Text] [Related]